ArticleNature communications2026
Molecular bridge engineering in covalent organic frameworks for enhanced electronic transport.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Conductive two-dimensional covalent organic frameworks (2D COFs) possess intrinsic π-conjugation and long-range order, yet their electrical performance in thin-film devices remains constrained by grain boundaries and amorphous regions that interrupt charge transport. Here we report a simple and scalable strategy to overcome these limitations by bridging polycrystalline COF domains with molecularly dispersed conjugated polymers (CPs). Guided by electronic alignment, geometric compatibility, and chain-length criteria, we identify COF-CP combinations that exhibit markedly enhanced conductivity when assembled into heterostructures. By demonstrating that electrical property enhancement occurs only below the CP crystallization threshold, we show that bridging CPs require short-range ordered or near-amorphous configurations to effectively span COF grains and establish continuous transport pathways. This approach is compatible with wafer-scale fabrication and enables ppb-level NO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.